QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
LON:VSN

Verseon (VSN) Share Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
74
▼
74
52-Week Range
N/A
Volume
3,000 shs
Average Volume
75,334 shs
Market Capitalization
£112.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsHeadlines

About Verseon

Verseon Corporation, a pharmaceutical company, designs and develops novel therapeutics for various diseases in the United States. The company is involved in developing oral anticoagulants for various cardiovascular indications with novel pharmacology; kallikrein inhibitors for the treatment of diabetic macular edema and hereditary angioedema; and novel angiogenesis inhibitors for the treatment of solid tumors. Verseon Corporation was founded in 2002 and is headquartered in Fremont, California.


VSN Stock News Headlines

August 15, 2023 | msn.com
What Time Is 'The Bachelorette's "Men Tell All" On? How To Watch Live On ABC And Hulu
August 11, 2023 | msn.com
Karlie Kloss attends Taylor Swift’s last Eras Tour concert amid feud rumours
September 25, 2023 | Chaikin Analytics (Ad)
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
August 9, 2023 | yahoo.com
New Van Halen Collection II Box Set Collects Sammy Hagar-Era Studio Albums, Rarities
July 23, 2023 | msn.com
First Look At State Department's New Armored Chevy Suburban
June 13, 2023 | msn.com
Aspyr to offer compensation following bizarre Star Wars classic DLC cancellation
November 12, 2022 | finance.yahoo.com
Verseon Acquires Edammo
November 8, 2021 | lse.co.uk
Verseon Corporation Share Chat
September 25, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
September 30, 2019 | www.lse.co.uk
Verseon Loss Worsens On Expenses; Share Price "Under Extreme Pressure"
June 28, 2019 | www.morningstar.co.uk
Verseon Reports Widened Loss In 2018 As Drug Development Advances
March 19, 2019 | www.morningstar.co.uk
Woodford Investment Management Backs Verseon In Share Placing (ALLISS)
March 18, 2019 | www.morningstar.co.uk
Verseon Mulls Fundraising Using Blockchain; Raises USD10 Million (ALLISS)
March 18, 2019 | finance.yahoo.com
Verseon Pioneers New Way of Funding Innovation Through Security Token Offering
March 18, 2019 | finance.yahoo.com
Fintech Pioneer Blockrules to Launch One of the World’s First Prospectus-Backed Global Security Token Offerings for Pharma Company Verseon
March 1, 2019 | www.msn.com
The dud that will blow up Washington
February 11, 2019 | finance.yahoo.com
Verseon Presents Two Precision Oral Anticoagulants with Low Bleeding at International Stroke Conference
February 4, 2019 | www.morningstar.co.uk
Verseon Starts Dosing In Phase I Clinical Trial Of VE?1902
February 4, 2019 | finance.yahoo.com
Verseon Reports First Dosing in Phase 1 Trial on New Precision Oral Anticoagulant
January 2, 2019 | finance.yahoo.com
Verseon unveils new blockchain technology
See More Headlines
Receive VSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verseon and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:VSN
CUSIP
N/A
CIK
N/A
Web
www.verseon.com
Phone
+1-510-2259000
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
74.84
Current Ratio
3.36
Quick Ratio
3.09

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
6.61
Book Value
GBX 21 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
151,674,000
Free Float
N/A
Market Cap
£112.24 million
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Adityo Prakash
    CEO & Exec. Director
  • Ms. Eniko Fodor (Age 51)
    Founder, CFO, COO, Company Sec. & Exec. Director

Key Competitors

View All Competitors













VSN Stock - Frequently Asked Questions

What is Verseon's stock symbol?

Verseon trades on the London Stock Exchange (LON) under the ticker symbol "VSN."

How do I buy shares of Verseon?

Shares of VSN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does Verseon make?

Verseon (LON:VSN) has a market capitalization of £0.00.

How can I contact Verseon?

Verseon's mailing address is 48820 Kato Rd Ste 100B, FREMONT, CA 94538-7323, United States. The official website for the company is www.verseon.com. The company can be reached via phone at +1-510-2259000.

This page (LON:VSN) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -